Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden

TI Verhoef; Ken Redekop; S Langenskiold; F Kamali; M Wadelius; G Burnside; AH Maitland-van der Zee; DA Hughes; M Pirmohamed

doi:10.1038/tpj.2016.41

Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden

TI Verhoef, Ken Redekop, S Langenskiold, F Kamali, M Wadelius, G Burnside, AH Maitland-van der Zee, DA Hughes, M Pirmohamed

Health Technology Assessment (HTA)

Research output: Contribution to journal › Article › Academic › peer-review

27 Citations (Scopus)

Original language	English
Pages (from-to)	478-484
Number of pages	7
Journal	Pharmacogenomics Journal
Volume	16
Issue number	5
DOIs	https://doi.org/10.1038/tpj.2016.41
Publication status	Published - 2016

Access to Document

10.1038/tpj.2016.41

http://hdl.handle.net/1765/95924

Cite this

@article{95b09e0bafcb4890b0549d0c1ecad31a,

title = "Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden",

author = "TI Verhoef and Ken Redekop and S Langenskiold and F Kamali and M Wadelius and G Burnside and {Maitland-van der Zee}, AH and DA Hughes and M Pirmohamed",

year = "2016",

doi = "10.1038/tpj.2016.41",

language = "English",

volume = "16",

pages = "478--484",

journal = "Pharmacogenomics Journal",

issn = "1470-269X",

publisher = "Nature Publishing Group",

number = "5",

}

TY - JOUR

T1 - Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden

AU - Verhoef, TI

AU - Redekop, Ken

AU - Langenskiold, S

AU - Kamali, F

AU - Wadelius, M

AU - Burnside, G

AU - Maitland-van der Zee, AH

AU - Hughes, DA

AU - Pirmohamed, M

PY - 2016

Y1 - 2016

U2 - 10.1038/tpj.2016.41

DO - 10.1038/tpj.2016.41

M3 - Article

SN - 1470-269X

VL - 16

SP - 478

EP - 484

JO - Pharmacogenomics Journal

JF - Pharmacogenomics Journal

IS - 5

ER -